What drives specialty drug pricing in the US?

Specialty drug pricing is driven by small patient populations (pricing power from limited alternatives), clinical differentiation (survival benefit commands premium), payer willingness-to-pay thresholds (typically $150K-200K per QALY in oncology), competitive dynamics within therapeutic class, and 340B ceiling price calculations that set a mathematical floor on WAC.